Advisory

Sustainability work that creates measurable business value

We are seasoned strategy consultants working with established companies, institutional investors, and public institutions. We work with sustainability across traditional business disciplines such as strategy, commercialisation, risk & resilience, cost efficiencies, energy security, operating model, supply chain engagement & management.

image-a57ad21139f612256914f4fecedb68bc2dcfb81c-7889x5262-jpg

We work in the intersection of sustainability and value creation

Sustainability work needs to drive business value. That’s what we help our clients achieve. These are some typical client challenges we help solve:

  • How do we integrate sustainability priorities into corporate strategy and turn progress into market advantage?
  • How do we reduce COGS and strengthen supply resilience through non-virgin materials and supplier engagement?
  • What are the biggest physical and transition risks to our business, and how do we mitigate them?
  • How do we engage with our suppliers to drive both emissions reduction and cost efficiency?
VALUE CREATIONSUSTAINABILITY
REVENUE UPLIFTCOST REDUCTION
RISK MANAGEMENTSUPPLY CHAIN RESILIENCE

We support clients driving sustainability forward from any starting point

We are seasoned management consultants with extensive experience from serving established companies, institutional investors, and public institutions on their most pressing topics within strategy, organisation and sustainability.

Read more about Advisory services
01ensuring compliance
02minimising business risks
03exploring opportunities
04reshaping company purpose
05transforming business

Our services cover every step of the sustainability journey — from ambition to action

View all services about Advisory services

Our advisory cases

We work with private companies, investors, government institutions, funds and foundations in both crafting sustainability strategies and actions while ensuring this work drives real value, impact and resilience. We are industry agnostic and advise companies of all sizes across the Nordics and globally.

See all about Our cases
The Footprint Firm Advisory

We offer a full range of services within sustainability

Learn moreabout Advisory services

Advisory

We help companies turn sustainability work into strategy, value & resilience across a wide range of areas of expertise. Always anchored in sound business logic, pragmatism and execution.

Learn more about Advisory services
image-1a0e35f270ea31447ca6af6ccd4b98ab4debf694-720x840-png

Zealand Pharma

CSRD readiness and ESG Strategy in healthcare

Zealand Pharma is an international biotechnology company developing innovative peptide-based medicines in three key therapeutic areas: obesity, rare diseases, and chronic inflammation. In preparation for upcoming CSRD requirements and to strengthen its sustainability ambitions, Zealand Pharma partnered with The Footprint Firm to develop a Double Materiality Assessment (DMA) and revisit its ESG strategy, linking regulatory compliance with long-term strategic value.

image-f6a653602c480a4aad5687923513329e692ea082-800x288-png

Services

Industries

  • Biotechnology
  • Pharmaceuticals & healthcare
The project

Zealand Pharma sought to establish a robust Double Materiality Assessment that could serve both as the analytical foundation for compliance and upcoming CSRD reporting and as a strategic tool to inform its ESG direction. The aim was to ensure cross-organisational alignment, engage senior leadership, and use the DMA process to guide the development of an updated, actionable ESG strategy.

Our approach

Working closely with the finance, strategy, and sustainability teams, we facilitated a CSRD-compliant DMA process grounded in stakeholder interviews and engagement with corporate management. The assessment identified material impacts, risks, and opportunities across environmental, social, and governance topics, aligned with CSRD requirements while tailored to Zealand Pharma’s unique context as a biotech innovator.


Building on this foundation, we co-developed an updated ESG strategy structured around three core pillars: Patients, People, and Operations. Each pillar was translated into clear initiatives, measurable targets, and linked CSRD datapoints, ensuring both strategic relevance and reporting readiness.

We also helped map internal ownership by connecting each pillar with relevant data owners and operational leads to embed sustainability across the organisation.

The impact

Our collaboration enabled Zealand Pharma to move from regulatory preparation to strategic integration, delivering a CSRD-ready Double Materiality Assessment and a refreshed ESG strategy rooted in business priorities.


The result: an ESG roadmap that is both compliant and value-generating, with clear internal ownership and a structure that connects Zealand Pharma’s mission to the company’s sustainability performance as a whole.